FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165694484> ?p ?o ?g. }

• W3165694484 endingPage "1709" @default.
• W3165694484 startingPage "1704" @default.
• W3165694484 abstract "Abstract Background Patients with chronic kidney disease, dialysis patients and kidney transplant patients are at high risk of developing severe coronavirus disease 2019 (COVID-19). Data regarding the immunogenicity of anti-severe acute respiratory syndrome coronavirus 2 messenger RNA (anti-SARS-CoV-2 mRNA) vaccines in dialysis patients were published recently. We assessed the immunogenicity of anti-SARS-CoV-2 mRNA vaccine in dialysis patients. Patients and methods One hundred and nine patients on haemodialysis (n = 85) or peritoneal dialysis (n = 24) have received two injections of 30-μg doses of BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech) that were administered intramuscularly 28 days apart. Those who were still seronegative after the second dose were given a third dose 1 month later. Anti-SARS-CoV-2 antibodies were tested before and after vaccination. Results Ninety-one out of the 102 patients who had at least a 1-month follow-up after the second (n = 97) or the third (n = 5) vaccine doses had anti-SARS-CoV-2 antibodies. The seroconversion rate was 88.7% (86 out of 97 patients) among SARS-CoV-2 seronegative patients at the initiation of vaccination. Receiving immunosuppressive therapy was an independent predictive factor for non-response to vaccination. Conclusion Due to high immunogenicity and safety of mRNA vaccines, we strongly recommend prioritizing a two-dose vaccination of dialysis patients. A third dose can be required in non-responders to two doses. When possible, patients waiting for a kidney transplantation should be offered the vaccine before transplantation." @default.
• W3165694484 created "2021-06-07" @default.
• W3165694484 creator A5009443613 @default.
• W3165694484 creator A5040346516 @default.
• W3165694484 creator A5040540371 @default.
• W3165694484 creator A5060713243 @default.
• W3165694484 creator A5068125354 @default.
• W3165694484 creator A5069001262 @default.
• W3165694484 creator A5072245706 @default.
• W3165694484 creator A5080763997 @default.
• W3165694484 creator A5085840168 @default.
• W3165694484 creator A5086280390 @default.
• W3165694484 creator A5088169312 @default.
• W3165694484 date "2021-05-31" @default.
• W3165694484 modified "2023-10-18" @default.
• W3165694484 title "High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients" @default.
• W3165694484 cites W2070111695 @default.
• W3165694484 cites W2977258778 @default.
• W3165694484 cites W3009260967 @default.
• W3165694484 cites W3031800140 @default.
• W3165694484 cites W3038852601 @default.
• W3165694484 cites W3093367571 @default.
• W3165694484 cites W3094775035 @default.
• W3165694484 cites W3111255098 @default.
• W3165694484 cites W3121611393 @default.
• W3165694484 cites W3125650891 @default.
• W3165694484 cites W3127628751 @default.
• W3165694484 cites W3129590436 @default.
• W3165694484 cites W3150786652 @default.
• W3165694484 cites W3155040466 @default.
• W3165694484 cites W3155408150 @default.
• W3165694484 cites W3157252954 @default.
• W3165694484 cites W3158948419 @default.
• W3165694484 cites W3162719213 @default.
• W3165694484 cites W3164162028 @default.
• W3165694484 cites W4205483821 @default.
• W3165694484 doi "https://doi.org/10.1093/ndt/gfab193" @default.
• W3165694484 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8195197" @default.
• W3165694484 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34057463" @default.
• W3165694484 hasPublicationYear "2021" @default.
• W3165694484 type Work @default.
• W3165694484 sameAs 3165694484 @default.
• W3165694484 citedByCount "83" @default.
• W3165694484 countsByYear W31656944842021 @default.
• W3165694484 countsByYear W31656944842022 @default.
• W3165694484 countsByYear W31656944842023 @default.
• W3165694484 crossrefType "journal-article" @default.
• W3165694484 hasAuthorship W3165694484A5009443613 @default.
• W3165694484 hasAuthorship W3165694484A5040346516 @default.
• W3165694484 hasAuthorship W3165694484A5040540371 @default.
• W3165694484 hasAuthorship W3165694484A5060713243 @default.
• W3165694484 hasAuthorship W3165694484A5068125354 @default.
• W3165694484 hasAuthorship W3165694484A5069001262 @default.
• W3165694484 hasAuthorship W3165694484A5072245706 @default.
• W3165694484 hasAuthorship W3165694484A5080763997 @default.
• W3165694484 hasAuthorship W3165694484A5085840168 @default.
• W3165694484 hasAuthorship W3165694484A5086280390 @default.
• W3165694484 hasAuthorship W3165694484A5088169312 @default.
• W3165694484 hasBestOaLocation W31656944841 @default.
• W3165694484 hasConcept C126322002 @default.
• W3165694484 hasConcept C159654299 @default.
• W3165694484 hasConcept C203014093 @default.
• W3165694484 hasConcept C22070199 @default.
• W3165694484 hasConcept C2777451964 @default.
• W3165694484 hasConcept C2778063415 @default.
• W3165694484 hasConcept C2778653478 @default.
• W3165694484 hasConcept C2779056158 @default.
• W3165694484 hasConcept C2779978075 @default.
• W3165694484 hasConcept C2780303639 @default.
• W3165694484 hasConcept C2780868878 @default.
• W3165694484 hasConcept C2911091166 @default.
• W3165694484 hasConcept C71924100 @default.
• W3165694484 hasConceptScore W3165694484C126322002 @default.
• W3165694484 hasConceptScore W3165694484C159654299 @default.
• W3165694484 hasConceptScore W3165694484C203014093 @default.
• W3165694484 hasConceptScore W3165694484C22070199 @default.
• W3165694484 hasConceptScore W3165694484C2777451964 @default.
• W3165694484 hasConceptScore W3165694484C2778063415 @default.
• W3165694484 hasConceptScore W3165694484C2778653478 @default.
• W3165694484 hasConceptScore W3165694484C2779056158 @default.
• W3165694484 hasConceptScore W3165694484C2779978075 @default.
• W3165694484 hasConceptScore W3165694484C2780303639 @default.
• W3165694484 hasConceptScore W3165694484C2780868878 @default.
• W3165694484 hasConceptScore W3165694484C2911091166 @default.
• W3165694484 hasConceptScore W3165694484C71924100 @default.
• W3165694484 hasIssue "9" @default.
• W3165694484 hasLocation W31656944841 @default.
• W3165694484 hasLocation W31656944842 @default.
• W3165694484 hasLocation W31656944843 @default.
• W3165694484 hasLocation W31656944844 @default.
• W3165694484 hasOpenAccess W3165694484 @default.
• W3165694484 hasPrimaryLocation W31656944841 @default.
• W3165694484 hasRelatedWork W1647607420 @default.
• W3165694484 hasRelatedWork W1988605508 @default.
• W3165694484 hasRelatedWork W2052413804 @default.
• W3165694484 hasRelatedWork W2314831483 @default.
• W3165694484 hasRelatedWork W2356105321 @default.
• W3165694484 hasRelatedWork W2371208792 @default.

• next